Volume 6 Supplement 2

Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts

Open Access

Electrostatic repulsion regulates hiv-1 capsid hexamer plasticity and assembling capacities into core-like structures

  • Sonia Brun1, 2, 3,
  • Laurent Chaloin1, 2, 3,
  • Bernard Gay1, 2, 3,
  • Eric Bernard1, 2, 3,
  • Christian Devaux1, 2, 3,
  • Corinne Lionne1, 2, 3,
  • Nathalie Chazal1, 2, 3 and
  • Laurence Briant1, 2, 3
Retrovirology20096(Suppl 2):P30

https://doi.org/10.1186/1742-4690-6-S2-P30

Published: 24 September 2009

Capsid protein (CA) is the major component of the HIV-1 core. Three major phosphorylation sites have been identified at positions S109, S149 and S178 in amino-acid sequence of CA. Here we investigated the possible consequences of phosphorylation at these sites on CA hexamer formation and core assembly. Using in silico modeling approaches we found that the presence of a phosphate group at each position impacts CA hexamer organization and flexibility. The biological relevance of molecular modeling was evaluated analyzing in vitro assembly properties of bacterially expressed CA bearing S109D, S149D or S178D substitutions that mimic constitutive phosphorylation at these sites. Constitutive negative charge at positions 109, 149 but not at position 178 impaired in vitro assembly of mature CA. In vivo, the corresponding mutations were found to impact the core morphology of HIV-1 mutants bearing the corresponding mutation. Moreover, these viruses lacked infectivity since they were unable to produce proviral DNA. Altogether our data indicate that phosphorylation may impact structural properties of CA hexamers and of HIV-1 cores. Its contribution in HIV-1 replication appears to play an important role in HIV-1 life cycle.

Authors’ Affiliations

(1)
Université Montpellier 1, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé (CPBS)
(2)
CNRS, UMR 5236, CPBS
(3)
Université Montpellier 2, CPBS

Copyright

© Brun et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement